<html>
<head>PUBMED IDs for ACZ</head>
<body bgcolor='#C5F0F2'><h1>ACZ</h1><a href='https://pubmed.ncbi.nlm.nih.gov/10662543/'>A novel family of bromodomain genes.</a> February 9  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/18463713/'>Mutation at tyrosine in AMLRY (GILRY like) motif of yeast eRF1 on nonsense codons suppression and binding affinity to eRF3.</a> May 9  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/20069137/'>Canakinumab for the treatment of cryopyrin-associated periodic syndromes.</a> April 9  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20357819/'>A transgenic mouse for imaging caspase-dependent apoptosis within the skin.</a> July 6  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21356079/'>Canakinumab (ACZ885, a fully human IgG1 anti-IL-1Î² mAb) induces sustained remission in pediatric patients with cryopyrin-associated periodic syndrome (CAPS).</a> February 11  2011<br></body></html>
